Hyderabad Telangana, India

Bommareddy Aggiramireddy


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bommareddy Aggiramireddy: Innovator in Pharmaceutical Patents

Introduction

Bommareddy Aggiramireddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cystic fibrosis. His innovative work has led to the creation of a patent that addresses critical medical needs.

Latest Patents

Aggiramireddy holds a patent for "Forms of lumacaftor and processes for the preparation thereof." This patent provides details on amorphous lumacaftor, amorphous solid dispersions of lumacaftor, crystalline lumacaftor acetic acid solvate, and crystalline lumacaftor ethyl acetate solvate. The forms disclosed in this patent may be useful for preparing oral dosage forms aimed at treating cystic fibrosis transmembrane conductance regulator (CFTR) mediated diseases. He has 1 patent to his name.

Career Highlights

Bommareddy Aggiramireddy is currently employed at Mylan Laboratories Limited, a leading global pharmaceutical company. His work at Mylan has allowed him to focus on innovative solutions that enhance patient care and treatment efficacy.

Collaborations

Aggiramireddy has collaborated with several professionals in his field, including Ramakoteswara Rao Jetti and Hemant Malhari Mande. These collaborations have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Bommareddy Aggiramireddy is a distinguished inventor whose work in pharmaceutical patents has the potential to significantly impact the treatment of cystic fibrosis. His contributions reflect a commitment to innovation and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…